⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10489503 | 1.00 | — | — | |
| SCHEMBL93407 | 1.00 | — | — | |
| SCHEMBL425852 | 1.00 | — | — | |
| SCHEMBL30033233 | 1.00 | — | — | |
| SCHEMBL842357 | 0.97 | — | — | |
| SCHEMBL8723287 | 0.97 | — | — | |
| SCHEMBL18259771 | 0.84 | ALDH1A1 (0.41) | — | |
| Tetrahydrofuran SCHEMBL8912584 | 0.81 | ALDH1A1 (0.40) | — | |
| SCHEMBL3668894 | 0.77 | ALDH1A1 (0.32) | — | |
| SCHEMBL17953985 | 0.77 | PTPN1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111253330-B | Novel crystal form of sartan drug, preparation method and application thereof | 广州白云山天心制药股份有限公司 | 2023-01-24 | — | — | CN | claimed |
| CN-101223149-A | Process for preparing valsartan | TEVA PHARMA (IL) | 2008-07-16 | — | — | CN | claimed |
| US-20240066141-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) | 2024-02-29 | — | — | US | disclosed |
| EP-4320254-A1 | SUSTAINABLE PROCESS FOR THE PREPARATION OF 5-METHYLHEPT-2-EN-4-ONE | Symrise AG (DE) | 2024-02-14 | — | — | EP | disclosed |
| US-20230382946-A1 | POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING | Changzhou University (CN) | 2023-11-30 | — | — | US | disclosed |
| US-20230310532-A1 | FOOD EXTRACTS, METHODS OF EXTRACTION AND COMPOSITIONS THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-10-05 | — | — | US | disclosed |
| CN-111253330-B | Novel crystal form of sartan drug, preparation method and application thereof | 广州白云山天心制药股份有限公司 | 2023-01-24 | — | — | CN | disclosed |
| WO-2022214180-A1 | SUSTAINABLE PROCESS FOR THE PREPARATION OF 5-METHYLHEPT-2-EN-4-ONE | SYMRISE AG (DE) | 2022-10-13 | — | — | WO | disclosed |
| US-20170349587-A1 | SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG | SHIONOGI & CO., LTD. (JP) | 2017-12-07 | — | — | US | disclosed |
| EP-3219743-A1 | HYDROPHOBICALLY MODIFIED UREA ETHERS AS STRUCTURANTS FOR HYDROPHOBIC SYSTEMS | Procter & Gamble International Operations SA (CH) | 2017-09-20 | — | — | EP | disclosed |
| US-9758515-B2 | Substituted polycyclic carbamoyl pyridone derivative prodrug | SHIONOGI & CO., LTD. (JP) | 2017-09-12 | — | — | US | disclosed |
| US-20090136974-A1 | Luciferin Luminescent Substrate of Marine Ostracod Crustacean and Method for Production Thereof | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE TECHNOLOGY (JP) | 2009-05-28 | — | — | US | disclosed |
| US-20090131372-A1 | PHOSPHONATE ANALOGS FOR TREATING METABOLIC DISEASES | CHEN JAMES M | 2009-05-21 | — | — | US | disclosed |
| WO-2009056539-A1 | FERMENTATIVE PRODUCTION OF SIMVASTATIN | DSM IP ASSETS B.V. (NL) | 2009-05-07 | — | — | WO | disclosed |
| EP-1213020-B1 | Compounds and pharmaceutical compositions having appetite suppressant activity | CSIR (ZA) | 2009-02-11 | — | — | EP | disclosed |
| US-20080200581-A1 | CURABLE COMPOSITION AND PROCESS FOR PRODUCING CURED COATING | FUJIFILM CORPORATION (JP) | 2008-08-21 | — | — | US | disclosed |
| CN-101223149-A | Process for preparing valsartan | TEVA PHARMA (IL) | 2008-07-16 | — | — | CN | disclosed |
| WO-2007147801-A1 | METHOD FOR THE PRODUCTION OF SIMVASTATIN | DSM IP ASSETS B.V. (NL) | 2007-12-27 | — | — | WO | disclosed |
| US-20070276138-A1 | Modulators of peroxisome proliferator activated receptors | BROOKS DAWN A | 2007-11-29 | — | — | US | disclosed |
| US-7192982-B2 | Modulators of peroxisome proliferator activated receptors | LIGAND PHARMACEUTICALS, INC. (US) | 2007-03-20 | — | — | US | disclosed |